Back to Search Start Over

RENEB Inter-Laboratory Comparison 2021 : The Gene Expression Assay

Authors :
Abend, M.
Amundson, S. A.
Badie, C.
Brzoska, K.
Kriehuber, R.
Lacombe, J.
López-Riego, Milagrosa
Lumniczky, K.
Endesfelder, D.
O'Brien, G.
Doucha-Senf, S.
Ghandhi, S. A.
Hargitai, R.
Kis, E.
Lundholm, Lovisa
Oskamp, D.
Ostheim, P.
Schüle, S.
Schwanke, D.
Shuryak, I.
Siebenwith, C.
Unverricht-Yeboah, M.
Wojcik, Andrzej
Yang, J.
Zenhausern, F.
Port, M.
Abend, M.
Amundson, S. A.
Badie, C.
Brzoska, K.
Kriehuber, R.
Lacombe, J.
López-Riego, Milagrosa
Lumniczky, K.
Endesfelder, D.
O'Brien, G.
Doucha-Senf, S.
Ghandhi, S. A.
Hargitai, R.
Kis, E.
Lundholm, Lovisa
Oskamp, D.
Ostheim, P.
Schüle, S.
Schwanke, D.
Shuryak, I.
Siebenwith, C.
Unverricht-Yeboah, M.
Wojcik, Andrzej
Yang, J.
Zenhausern, F.
Port, M.
Publication Year :
2023

Abstract

Early and high-throughput individual dose estimates are essential following large-scale radiation exposure events. In the context of the Running the European Network for Biodosimetry and Physical Dosimetry (RENEB) 2021 exercise, gene expression assays were conducted and their corresponding performance for dose-assessment is presented in this publication. Three blinded, coded whole blood samples from healthy donors were exposed to 0, 1.2 and 3.5 Gy X-ray doses (240 kVp, 1 Gy/min) using the X-ray source Yxlon. These exposures correspond to clinically relevant groups of unexposed, low dose (no severe acute health effects expected) and high dose exposed individuals (requiring early intensive medical health care). Samples were sent to eight teams for dose estimation and identification of clinically relevant groups. For quantitative reverse transcription polymerase chain reaction (qRT-PCR) and microarray analyses, samples were lysed, stored at 20°C and shipped on wet ice. RNA isolations and assays were run in each laboratory according to locally established protocols. The time-to-result for both rough early and more precise later reports has been documented where possible. Accuracy of dose estimates was calculated as the difference between estimated and reference doses for all doses (summed absolute difference, SAD) and by determining the number of correctly reported dose estimates that were defined as ±0.5 Gy for reference doses <2.5 Gy and ±1.0 Gy for reference doses >3 Gy, as recommended for triage dosimetry. We also examined the allocation of dose estimates to clinically/diagnostically relevant exposure groups. Altogether, 105 dose estimates were reported by the eight teams, and the earliest report times on dose categories and estimates were 5 h and 9 h, respectively. The coefficient of variation for 85% of all 436 qRT-PCR measurements did not exceed 10%. One team reported dose estimates that systematically deviated several-fold from reported dose estimates, and

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1457483036
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1667.RADE-22-00206.1